Lushang Freda Pharmaceutical Co (SHSE:600223) EPS (Basic) : ¥0.23 (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co EPS (Basic)?

Lushang Freda Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.23.

Lushang Freda Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.23.

Lushang Freda Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.27.

During the past 12 months, Lushang Freda Pharmaceutical Co's average EPS without NRIGrowth Rate was -1.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -39.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -13.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Lushang Freda Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 137.60% per year. The lowest was -46.40% per year. And the median was -10.80% per year.

Lushang Freda Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co EPS (Basic) Chart

Lushang Freda Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.34

0.64

0.36

0.04

0.30

Lushang Freda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.13	0.06	0.04	0.07	0.06

Lushang Freda Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Lushang Freda Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(303.387	-	0)	/	1011.291
	=	0.30

Lushang Freda Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(59.037	-	0)	/	983.945
	=	0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.23

Lushang Freda Pharmaceutical Co (SHSE:600223) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Lushang Freda Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN

Website

http://www.lshzy.com.cn

Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.

Executives

Li Hang	senior management
Yin Wei	Directors, senior managers
Shao Zhao Wei	senior management
Wang Zhong Wu	senior management
Dong Hong Lin	Director
Zhou Hong Bo	senior management
Li Lu	senior management
Liu Zeng Wei	senior management
Zhang Quan Li	senior management
Xu Tao	senior management
Ju Hai Bo	Director
Zhao Xi Liang	Director
Pi Xi Cai	Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines